Expression of tumour necrosis factor-alpha in the rat dental follicle

Archives of Oral Biology

Volumn 48, Issue 1, 2003, Pages 47-54

  Wise, Gary E ^a   Yao, Shaomian ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Dental follicle; MCP 1; TNF ; Tooth eruption; VEGF

Indexed keywords

EID: 0037265530     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(02)00153-X     Document Type: Article

References (59)

1. Standiford TJ. Anti-inflammatory cytokines and cytokine antagonists. Curr Pharm Design 2000;6:633-649.
2. Rossomando EF, Kennedy JE, Hadjimichael J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990;35:431-434.
3. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991;62:504-509.
4. 2 and tumour necrosis factor α in experimental gingivitis in humans. J Periodontal Res 1993;28:241-247.
5. Roberts FA, Mccaffery KA, Michalek SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997;76:1833-1839.
6. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997;94:8093-8098.
7. Ma X. TNF-α and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001;3:121-129.
8. Muniz-Junqueira MI, dos Santos-Neto LL, Tosta CE. Influence of tumor necrosis factor-α on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cell Immunol 2001;208:73-79.
9. Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Graves BD, Einhorn TA. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cell Tissue Organ 2001;169:285-294.
10. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
11. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
12. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
13. Tsuda E, Goto M, Mochizuki S-I, Yano K, Kobayashi F, Morinaga T, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137-142.
14. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-1337.
15. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-285.
16. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J Biol Chem 2000;275:4858-4864.
17. Lain J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000;106:1481-1488.
18. Zhang Y-H, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y. Tumor necrosis factor-α (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 2001;276:563-568.
19. Wise GE, Marks Jr SC, Cahill DR. Ultrastructural features of the dental follicle associated with formation of the tooth eruption pathway in the dog. J Oral Pathol Med 1985;14:15-26.
20. Wise GE, Lumpkin SJ, Huang H, Zhang Q. Osteoprotegerin and osteoclast differentiation factor in tooth eruption. J Dent Res 2000a;79:1937-1942.
21. Iizuka T, Cielinski M, Aukerman SL, Marks Jr SC. The effects of colony-stimulating factor-1 on tooth eruption in the toothless (osteopetrotic) rat in relation to the critical periods for bone resorption during tooth eruption. Arch Oral Biol 1992;37:629-636.
22. Marks Jr SC, Cielinski MJ, Sundquist K, Wise GE, Gorski JP, 1994. The role of bone resorption in tooth eruption. In: Davidovitch Z, editor. The Biological Mechanisms of Tooth Eruption, Resorption and Replacement by Implants. EBSCO Media, Birmingham, AL, pp. 483-488.
23. Grier RL, Wise GE. Inhibition of tooth eruption in the rat by a bisphosphonate. J Dent Res 1998;77:8-15.
24. Cahill DR, Marks Jr SC. Tooth eruption: evidence for the central role of the dental follicle. J Oral Pathol Med 1980;9:189-200.
25. Marks Jr SC, Cahill DR. Experimental study in the dog of the non-active role of the tooth in the eruptive process. Arch Oral Biol 1984;29:311-322.
26. Ureles SD, Chrzan JM, Norton LA, Rossomando EF. A role for TNF in bone resorption of deciduous molars in human beings. Am J Orthod Dentofacial Orthop 2000;118:196-202.
27. Nakchbandi IA, Weir EE, Insogna KL, Philbrick WM, Broadus AE. Parathyroid hormone-related protein induces spontaneous osteoclast formation via a paracrine cascade. Proc Natl Acad Sci USA 2000;97:7296-7300.
28. Lee H-J, Kang I-K, Chung C-P, Choi S-M. The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol 1995;22:885-890.
29. Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 1998;33:212-225.
30. Wise GE, Lin F, Fan W. Culture and characterization of dental follicle cells from rat molars. Cell Tissue Res 1992;267:483-492.
31. Yoshimura T, Takeya M, Takahashi K. Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 1991;174:504-509.
32. Burchardt M, Burchardt T, Chen M-W, Shabsigh A, de la Taille A, Buttyan R, et al. Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans. Biol Reprod 1999;60:398-404.
33. Liu M-T, Huang H-M, Jeng K-CG, Ou S-C, Kuo J-S. Induction of cytokine genes and IL-1α by chemical hypoxia in PC12 cells. Life Sci 2000;67:2147-2157.
34. Wise GE, Lin F, Zhao L. Immunolocalization of interleukin-1α in rat mandibular molars and its enhancement after in viva injection of epidermal growth factor. Cell Tissue Res 1995;280:21-26.
35. Huang H, Wise GE. Delay of tooth eruption in null mice devoid of the type I IL-1R gene. Eur J Oral Sci 2000;108:297-302.
36. Wise GE, Lumpkin SJ, Huang H. Effects of injection of IL-1α on tooth eruption in the rat. Int J Oral Biol 2000b;25:39-45.
37. Kaplan DL, Eielson CM, Horowitz MC, Insogna KL, Weir EC. Tumor necrosis factor-alpha induces transcription of the colony-stimulating factor-1 gene in murine osteoblasts. J Cell Physiol 1996;168:199-208.
38. Yao GQ, Sun B, Hammond EE, Spencer EN, Horowitz MC, Insogna KL, et al. The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem 1998;273:4119-4128.
39. Giroir BP, Brown T, Beutler B. Constitutive synthesis of tumor necrosis factor in the thymus. Proc Natl Acad Sci USA 1992;89:4864-4868.
40. Wise GE, Fan W. Changes in the tartrate-resistant acid phosphatase cell population in dental follicles and bony crypts of rat molars during tooth eruption. J Dent Res 1989;68:150-156.
41. Cielínski MJ, Jolie M, Wise GE, Ando DG, Marks Jr, SC, 1994. Colony-stimulating factor-1 (CSF-1) is a potent stimulator of tooth eruption in the rat. In: Davidovitch Z, editor. The Biological Mechanisms of Tooth Eruption, Resorption and Replacement by Implants. EBSCO Media, Birmingham, AL, pp. 429-436.
42. Graves DT, Jiang Y. Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med 1995;6:109-118.
43. Penberthy TW, Jiang Y, Graves DT. Leukocyte adhesion molecules. Crit Rev Oral Biol Med 1997;8:380-388.
44. Que BG, Wise GE. Colony-stimulating factor-1 and monocyte chemotactic protein-1 chemotaxis for monocytes in the rat dental follicle. Arch Oral Biol 1997;42:855-860.
45. Que BG, Wise GE. Tooth eruption molecules enhance MCP-1 gene expression in the dental follicle of the rat. Dev Dyn 1998;212:346-351.
46. McGowan NWA, Walker EJ, Macpherson H, Ralston SH, Helfrich MH. Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology 2001;142:1678-1681.
47. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999;190:293-298.
48. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
49. Tervahartiala T, Koski H, Xu J-W, Häyrinen-Immonen R, Hietanen J, Sorsa T, et al. Tumor necrosis factor-α and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001;80:1535-1539.
50. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunology 1992;76:42-47.
51. Williams RC. Periodontal disease. New Engl J Med 1990;322:373-376.
52. Alexander MB, Damoulis PD, 1994. The role of cytokines in the pathogenesis of periodontal disease. Curr Opin Periodontol 39-53.
53. Lima V, Bezerra MM, Alencar VBM, Vidal FDP, Rocha FAC, Brito GAC, et al. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000;108:123-129.
54. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001;28:233-240.
55. Sakata M, Shiba H, Komatsuzawa H, Fujita T, Ohta K, Sugai M, et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. J Bone Miner Res 1999;14:1486-1492.
56. Oyama T, Sakuta T, Matsushita K, Maruyama I, Nagaoka S, Torii M. Effects of Roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture. J Periodontol 2000;71:1546-1553.
57. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 1998;33:491-499.
58. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
59. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J Clin Periodontol 1999;26:183-189.